QIAGEN Competitors and Similar CompaniesClear all
QIAGEN's competitors and similar companies include bioMerieux and Illumina.
 bioMerieux bioMérieux (formerly known as B-D Mérieux) is a company that develops and manufactures in vitro diagnostic systems. |  Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. | ||
Founding Date | Founding Date 1984 | Founding Date 1963 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more | Locations Lyon, FR HQ Dely Ibrahim, DZ Buenos Aires, AR Buenos Aires, AR North Ryde, AU North Ryde, AU Wien, AT see more | Locations San Diego, US HQ Melbourne, AU Wien, AT Mechelen, BE Sao Paulo, BR Vancouver, CA Beijing, CN see more |
Employees | Employees 5,4913% decrease | Employees 14,600 | Employees 8,6004% decrease |
Valuation ($) | Valuation ($) 9.3 b | Valuation ($) 13.7 b | Valuation ($) 23.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $2.1b (FY, 2025) | Revenue (est.) €4b (FY, 2025) | Revenue (est.) $4.3b (FY, 2025) |
Cost of goods | Cost of goods $577.3m (FY, 2025) | Cost of goods €1.3b (FY, 2025) | Cost of goods $1.5b (FY, 2025) |
Gross profit | Gross profit $1.5b (FY, 2025) | Gross profit €2.8b (FY, 2025) | Gross profit $2.9b (FY, 2025) |
Net income | Net income $437m (FY, 2025) | Net income €397m (FY, 2025) | Net income $850m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 4m | Total funding raised N/A | Total funding raised $ 28m |
For sources of this data, please see the company profile
View Company Profiles
bioMerieux
HQ
Lyon, FR
Employees
14,600
bioMérieux (formerly known as B-D Mérieux) is a company that develops and manufactures in vitro diagnostic systems.
View companyIllumina
HQ
San Diego, US
Employees
8,600↓ 4% decrease
Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis.
View company